Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Sargramostim to Prevent Mucositis in Patients Receiving Radiation Therapy for Laryngeal Cancer
This study is ongoing, but not recruiting participants.
Study NCT00004256 Information provided by National Cancer Institute (NCI)
First Received: January 28, 2000 Last Updated: August 19, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Head and Neck Cancer
Oral Complications
Radiation Toxicity
Additional conditions recognized in this trial
Head and Neck Neoplasms
Laryngeal Neoplasms
Mucositis
More general conditions related to this trial
Digestive System Diseases
Gastroenteritis
Gastrointestinal Diseases
Laryngeal Diseases
Mouth Diseases
Neoplasms
Neoplasms by Site
Otorhinolaryngologic Diseases
Otorhinolaryngologic Neoplasms
Respiratory Tract Diseases
Respiratory Tract Neoplasms
Stomatognathic Diseases
Interventions listed in this trial
sargramostim
quality-of-life assessment
radiation therapy
Sponsors listed in this trial
Royal Marsden - London
Back to top of Main Content